 treehouse1977 (CC BY-SA 2.0)
|
Manufacturing problems, few market incentives for the production of low-profit drugs and government inaction are leaving thousands of patients without essential medicine and creating complications usually seen only in the developing world, if ever.
Posted on May 24, 2013
READ MORE
|